GENERATE Trademark

Trademark Overview

On Thursday, November 21, 2019, a trademark application was filed for GENERATE with the United States Patent and Trademark Office. The USPTO has given the GENERATE trademark a serial number of 88701131. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 15, 2025. This trademark is owned by Flagship VL56, Inc.. The GENERATE trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

pharmaceutical preparations for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders but excluding DNA-based gene therapy; therapeutic products for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatri...

biological and chemical agents for scientific and research use

General Information

Serial Number88701131
Word MarkGENERATE
Filing DateThursday, November 21, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 18, 2020

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders but excluding DNA-based gene therapy; therapeutic products for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy
Goods and Servicesbiological and chemical agents for scientific and research use

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, November 27, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 26, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENERATE BIOMEDICINES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143
Party NameGENERATE BIOMEDICINES, INC.
Party Type12 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameGENERATE BIOLOGICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameFlagship VL56, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Wednesday, November 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 27, 2019ASSIGNED TO EXAMINER
Wednesday, February 12, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, April 29, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, June 26, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 26, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, December 28, 2019NON-FINAL ACTION WRITTEN
Saturday, December 28, 2019NON-FINAL ACTION E-MAILED
Saturday, December 28, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 26, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, October 16, 2020ASSIGNED TO PETITION STAFF
Tuesday, August 18, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 2, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, September 16, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, October 22, 2020POST PUBLICATION AMENDMENT - ENTERED
Wednesday, October 28, 2020OPPOSITION INSTITUTED NO. 999999
Wednesday, June 29, 2022OPPOSITION TERMINATED NO. 999999
Wednesday, June 29, 2022OPPOSITION DISMISSED NO. 999999
Wednesday, June 29, 2022TTAB RELEASE CASE TO TRADEMARKS
Tuesday, August 9, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 22, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 20, 2023SOU TEAS EXTENSION RECEIVED
Friday, January 20, 2023SOU EXTENSION 1 FILED
Friday, January 20, 2023SOU EXTENSION 1 GRANTED
Tuesday, January 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 20, 2023SOU EXTENSION 2 FILED
Thursday, July 20, 2023SOU EXTENSION 2 GRANTED
Monday, February 5, 2024SOU TEAS EXTENSION RECEIVED
Monday, February 5, 2024SOU EXTENSION 3 FILED
Monday, February 5, 2024SOU EXTENSION 3 GRANTED
Wednesday, February 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 20, 2023SOU TEAS EXTENSION RECEIVED
Saturday, July 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 17, 2024SOU EXTENSION 4 FILED
Wednesday, July 17, 2024SOU EXTENSION 4 GRANTED
Monday, January 13, 2025SOU EXTENSION 5 FILED
Monday, January 13, 2025SOU TEAS EXTENSION RECEIVED
Monday, February 3, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 3, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 3, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 17, 2025SOU EXTENSION 5 GRANTED
Friday, April 18, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 3, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 3, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 3, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 15, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, September 15, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, September 3, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 17, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 3, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

generate diseases disorders treatment gastrointestinal infectious cardiovascular endocrine cancer autoimmune gene